Bradykinin‐induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3‐K/Akt in vascular smooth muscle cells
- 30 November 2004
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 203 (3), 538-546
- https://doi.org/10.1002/jcp.20250
Abstract
In our previous study, bradykinin (BK) exerts its mitogenic effect through Ras/Raf/MEK/MAPK pathway in vascular smooth muscle cells (VSMCs). In addition to this pathway, the non-receptor tyrosine kinases (Src), EGF receptor (EGFR), and phosphatidylinositol 3-kinase (PI3-K) have been implicated in linking a variety of G-protein coupled receptors to MAPK cascades. Here, we investigated whether these different mechanisms participating in BK-induced activation of p42/p44 MAPK and cell proliferation in VSMCs. We initially observed that BK- and EGF-dependent activation of Src, EGFR, Akt, and p42/p44 MAPK and [3H]thymidine incorporation were mediated by Src and EGFR, because the Src inhibitor PP1 and EGFR kinase inhibitor AG1478 abrogated BK- and EGF-dependent effects. Inhibition of PI3-K by LY294002 attenuated BK-induced Akt and p42/p44 MAPK phosphorylation and [3H]thymidine incorporation, but had no effect on EGFR phosphorylation, suggesting that EGFR may be an upstream component of PI3-K/Akt and MAPK in these responses. This hypothesis was supported by the tranfection with dominant negative plasmids of p85 and Akt which significantly attenuated BK-induced Akt and p42/p44 MAPK phosphorylation. Pretreatment with U0126 (a MEK1/2 inhibitor) attenuated the p42/p44 MAPK phosphorylation and [3H]thymidine incorporation stimulated by BK, but had no effect on Akt activation. Moreover, BK-induced transactivation of EGFR and cell proliferation was blocked by matrix metalloproteinase inhibitor GM6001. These results suggest that, in VSMCs, the mechanism of BK-stimulated activation of p42/p44 MAPK and cell proliferation was mediated, at least in part, through activation of Src family kinases, EGFR transactivation, and PI3-K/Akt. CopyrightKeywords
This publication has 47 references indexed in Scilit:
- ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Bradykinin B2 Receptor-Mediated Proliferation via Activation of the Ras/Raf/MEK/MAPK Pathway in Rat Vascular Smooth Muscle CellsJournal of Biomedical Science, 2003
- Ligand-independent trans-Activation of the Platelet-derived Growth Factor Receptor by Reactive Oxygen Species Requires Protein Kinase C-δ and c-SrcJournal of Biological Chemistry, 2002
- Phospholipase D—Structure, regulation and functionReviews of physiology, biochemistry and pharmacology, 2001
- Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle CellsPublished by Elsevier BV ,2001
- Carbachol-stimulated Transactivation of Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase in T84 Cells Is Mediated by Intracellular Ca2+, PYK-2, and p60Journal of Biological Chemistry, 2000
- A Novel Mitogenic Signaling Pathway of Bradykinin in the Human Colon Carcinoma Cell Line SW-480 Involves Sequential Activation of a Gq/11 Protein, Phosphatidylinositol 3-Kinase β, and Protein Kinase CεPublished by Elsevier BV ,1998
- Phosphatidylinositol 3-Kinase Is an Early Intermediate in the Gβγ-mediated Mitogen-activated Protein Kinase Signaling PathwayJournal of Biological Chemistry, 1996
- Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptorsNature, 1996
- Mechanism of the antihypertensive effect of K depletion in the spontaneously hypertensive ratKidney International, 1988